Don't Ignore This Potential Blockbuster (The Motley Fool)
Five trials later, Roche's taspoglutide seems like a winner.
Information on the Avandia Search Engine which indexes selected sites that offer medical and legal information on the diabetic drug Avandia which was found to cause heart attacks and other heart-related health problems.
0 Comments:
Post a Comment
Links to this post:
Create a Link
<< Home